Inventor
NAKADE SHINJI
JP17 patents
⚠️ This page may combine multiple inventors who share the name “NAKADE SHINJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONO PHARMACEUTICAL CO
11 patentsUS8039674B2Oct 18, 2011
Compound having S1P receptor binding potency and use thereof
ONO PHARMACEUTICAL CO28 citations92
US7300917B2Nov 27, 2007
Remedy for chronic disease
ONO PHARMACEUTICAL CO25 citations92
US7288558B2Oct 30, 2007
Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator
ONO PHARMACEUTICAL CO35 citations92
US7825109B2Nov 2, 2010
Compound capable of binding S1P receptor and pharmaceutical use thereof
ONO PHARMACEUTICAL CO27 citations89
US7906549B2Mar 15, 2011
Aminocarboxylic acid derivative and medicinal use thereof
ONO PHARMACEUTICAL CO11 citations82
US7820682B2Oct 26, 2010
LPA receptor antagonist
ONO PHARMACEUTICAL CO14 citations82
US7285680B2Oct 23, 2007
β-alanine derivatives and the use thereof
ONO PHARMACEUTICAL CO19 citations82
US7700792B2Apr 20, 2010
Highly active lysophosphatidic acid and method of screening therewith
ONO PHARMACEUTICAL CO8 citations81
US6252056B1Jun 26, 2001
Human lysophosphatidic acid receptor and use thereof
ONO PHARMACEUTICAL CO6 citations68
US7875745B2Jan 25, 2011
Compounds having lysophosphatidic acid receptor antagonism and uses thereof
ONO PHARMACEUTICAL CO6 citations62
US7511159B2Mar 31, 2009
Azetidine ring compounds and drugs comprising the same
ONO PHARMACEUTICAL CO0 citations49
NAKADE SHINJI
3 patentsUS8791159B2Jul 29, 2014
Compound capable of binding S1P receptor and pharmaceutical use thereof
NAKADE SHINJI1 citations46
US8673889B2Mar 18, 2014
BLT2-mediated disease, BLT2 binding agent and the compound
NAKADE SHINJI0 citations39
US8765783B2Jul 1, 2014
Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation
NAKADE SHINJI0 citations35